Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William B Messer

Showing results (31-40 of 81) with videos related to

Pageof 9
Sort By:
The Journal of Infectious Diseases|December 5, 2021
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Specific Memory B Cells From Individuals With Diverse Disease Severities Recognize SARS-CoV-2 Variants of ConcernZoe L Lyski, Amanda E Brunton, Matt I Strnad, et al.
Medrxiv : the Preprint Server for Health Sciences|June 8, 2021
SARS-CoV-2 specific memory B-cells from individuals with diverse disease severities recognize SARS-CoV-2 variants of concernZoe L Lyski, Amanda E Brunton, Matt I Strnad, et al.
Frontiers in Neurology|March 21, 2022
Case Report: Yellow Fever Vaccine-Associated Neurotropic Disease and Associated MRI, EEG, and CSF FindingsMichelle Cohen, Madeline Nguyen, Chad D Nix, et al.
JCI Insight|January 26, 2023
An extended interval between vaccination and infection enhances hybrid immunity against SARS-CoV-2 variantsTimothy A Bates, Hans C Leier, Savannah K McBride, et al.
Medrxiv : the Preprint Server for Health Sciences|January 19, 2023
The time between vaccination and infection impacts immunity against SARS-CoV-2 variantsTimothy A Bates, Hans C Leier, Savannah K McBride, et al.
The Journal of Clinical Investigation|January 16, 2024
Contralateral second dose improves antibody responses to a 2-dose mRNA vaccination regimenSedigheh Fazli, Archana Thomas, Abram E Estrada, et al.
Immunology|May 31, 2021
Non-structural protein 1-specific antibodies directed against Zika virus in humans mediate antibody-dependent cellular cytotoxicityLuis A Sanchez Vargas, Awadalkareem Adam, Mary Masterson, et al.
Indoor Air|June 30, 2021
Identification of SARS-CoV-2 RNA in healthcare heating, ventilation, and air conditioning unitsPatrick F Horve, Leslie G Dietz, Mark Fretz, et al.
Blood Cells, Molecules & Diseases|May 19, 2024
Extreme γ' fibrinogen levels in COVID-19 patientsMatthew Hudkins, Heather Hamilton, Samantha J Underwood, et al.
Medrxiv : the Preprint Server for Health Sciences|September 14, 2021
Immunogenicity of Pfizer mRNA COVID-19 vaccination followed by J&J adenovirus COVID-19 vaccination in two CLL patientsZoe L Lyski, Sunny Kim, David Xthona Lee, et al.
Pageof 9

Showing results (31-40 of 81) with videos related to

Sort By:
Pageof 9
The Journal of Infectious Diseases|December 5, 2021
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Specific Memory B Cells From Individuals With Diverse Disease Severities Recognize SARS-CoV-2 Variants of ConcernZoe L Lyski, Amanda E Brunton, Matt I Strnad, et al.
Medrxiv : the Preprint Server for Health Sciences|June 8, 2021
SARS-CoV-2 specific memory B-cells from individuals with diverse disease severities recognize SARS-CoV-2 variants of concernZoe L Lyski, Amanda E Brunton, Matt I Strnad, et al.
Frontiers in Neurology|March 21, 2022
Case Report: Yellow Fever Vaccine-Associated Neurotropic Disease and Associated MRI, EEG, and CSF FindingsMichelle Cohen, Madeline Nguyen, Chad D Nix, et al.
JCI Insight|January 26, 2023
An extended interval between vaccination and infection enhances hybrid immunity against SARS-CoV-2 variantsTimothy A Bates, Hans C Leier, Savannah K McBride, et al.
Medrxiv : the Preprint Server for Health Sciences|January 19, 2023
The time between vaccination and infection impacts immunity against SARS-CoV-2 variantsTimothy A Bates, Hans C Leier, Savannah K McBride, et al.
The Journal of Clinical Investigation|January 16, 2024
Contralateral second dose improves antibody responses to a 2-dose mRNA vaccination regimenSedigheh Fazli, Archana Thomas, Abram E Estrada, et al.
Immunology|May 31, 2021
Non-structural protein 1-specific antibodies directed against Zika virus in humans mediate antibody-dependent cellular cytotoxicityLuis A Sanchez Vargas, Awadalkareem Adam, Mary Masterson, et al.
Indoor Air|June 30, 2021
Identification of SARS-CoV-2 RNA in healthcare heating, ventilation, and air conditioning unitsPatrick F Horve, Leslie G Dietz, Mark Fretz, et al.
Blood Cells, Molecules & Diseases|May 19, 2024
Extreme γ' fibrinogen levels in COVID-19 patientsMatthew Hudkins, Heather Hamilton, Samantha J Underwood, et al.
Medrxiv : the Preprint Server for Health Sciences|September 14, 2021
Immunogenicity of Pfizer mRNA COVID-19 vaccination followed by J&J adenovirus COVID-19 vaccination in two CLL patientsZoe L Lyski, Sunny Kim, David Xthona Lee, et al.
Pageof 9